The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Ben.Reynolds@glasgow.ac.uk
Royal Hospital for Children, 1345, Govan Road, Glasgow, G51 4TF
Henderson, S., Ardill, R., Reynolds, B. and Kavanagh, D. (2022) Use of a B-cell depleting regimen for antifactor H autoantibody-mediated membranoproliferative glomerulonephritis in a paediatric patient. BMJ Case Reports, 15(4), e246281. (doi: 10.1136/bcr-2021-246281) (PMID:35444020)
Patterson, J., Jacob, Z. and Reynolds, B. C. (2022) Genetic evaluation of paediatric nephrocalcinosis: phenotype-driven genetic panels reveal a rare diagnosis. Clinical Kidney Journal, 15(4), pp. 812-815. (doi: 10.1093/ckj/sfab279) (PMID:35371448)
Reynolds, B. C., Lamb, A., Jones, C. A., Yadav, P., Tyerman, K. S. and Geddes, C. C. (2022) UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant. Pediatric Nephrology, 37(1), pp. 199-207. (doi: 10.1007/s00467-021-05248-9) (PMID:34383125) (PMCID:PMC8674165)
Dobbie, L. J., Lamb, A., Eskell, L., Ramage, I. J. and Reynolds, B. C. (2021) Thromboprophylaxis in congenital nephrotic syndrome: 15 year experience from a national cohort. Pediatric Nephrology, 36(5), pp. 1183-1194. (doi: 10.1007/s00467-020-04793-z) (PMID:33089377)
Bruce, G., Chaudhury, S. and Reynolds, B. (2020) Bilateral primary renal diffuse large B-cell lymphoma: a rare presentation of paediatric renal disease mimicking juvenile nephronophthisis. BMJ Case Reports, 13(2), e234810. (doi: 10.1136/bcr-2020-234810) (PMID:32675115)
Harkins, V.J. , McAllister, D.A. and Reynolds, B.C. (2020) Shiga-toxin E. coli Hemolytic Uremic Syndrome: review of management and long-term outcome. Current Pediatrics Reports, 8, pp. 16-25. (doi: 10.1007/s40124-020-00208-7)
Maxted, A. P., Dalrymple, R. A., Chisholm, D., McColl, J. , Tse, Y., Christian, M. T. and Reynolds, B. C. (2019) Low dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome. Pediatric Nephrology, 34(5), pp. 855-863. (doi: 10.1007/s00467-018-4172-3) (PMID:30564878) (PMCID:PMC6424916)
Henderson, S., Ardill, R., Reynolds, B. and Kavanagh, D. (2022) Use of a B-cell depleting regimen for antifactor H autoantibody-mediated membranoproliferative glomerulonephritis in a paediatric patient. BMJ Case Reports, 15(4), e246281. (doi: 10.1136/bcr-2021-246281) (PMID:35444020)
Patterson, J., Jacob, Z. and Reynolds, B. C. (2022) Genetic evaluation of paediatric nephrocalcinosis: phenotype-driven genetic panels reveal a rare diagnosis. Clinical Kidney Journal, 15(4), pp. 812-815. (doi: 10.1093/ckj/sfab279) (PMID:35371448)
Reynolds, B. C., Lamb, A., Jones, C. A., Yadav, P., Tyerman, K. S. and Geddes, C. C. (2022) UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant. Pediatric Nephrology, 37(1), pp. 199-207. (doi: 10.1007/s00467-021-05248-9) (PMID:34383125) (PMCID:PMC8674165)
Dobbie, L. J., Lamb, A., Eskell, L., Ramage, I. J. and Reynolds, B. C. (2021) Thromboprophylaxis in congenital nephrotic syndrome: 15 year experience from a national cohort. Pediatric Nephrology, 36(5), pp. 1183-1194. (doi: 10.1007/s00467-020-04793-z) (PMID:33089377)
Bruce, G., Chaudhury, S. and Reynolds, B. (2020) Bilateral primary renal diffuse large B-cell lymphoma: a rare presentation of paediatric renal disease mimicking juvenile nephronophthisis. BMJ Case Reports, 13(2), e234810. (doi: 10.1136/bcr-2020-234810) (PMID:32675115)
Harkins, V.J. , McAllister, D.A. and Reynolds, B.C. (2020) Shiga-toxin E. coli Hemolytic Uremic Syndrome: review of management and long-term outcome. Current Pediatrics Reports, 8, pp. 16-25. (doi: 10.1007/s40124-020-00208-7)
Maxted, A. P., Dalrymple, R. A., Chisholm, D., McColl, J. , Tse, Y., Christian, M. T. and Reynolds, B. C. (2019) Low dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome. Pediatric Nephrology, 34(5), pp. 855-863. (doi: 10.1007/s00467-018-4172-3) (PMID:30564878) (PMCID:PMC6424916)